Esperion Therapeutics Inc (NAS:ESPR)
$ 2.12 0.12 (6%) Market Cap: 416.00 Mil Enterprise Value: 472.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Esperion Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 09:30PM GMT
Release Date Price: $7.3 (+0.55%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good afternoon, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we are delighted to be continuing the conference today with Esperion. We're not going to switch rooms for Q&A. Instead, if you have a question after the presentation, you can raise your hand, so one will bring you a microphone or you can submit your questions electronically as well.

So with that out of the way, let me turn it over to Esperion CEO, Sheldon Koenig, for the presentation.

Sheldon L. Koenig
Esperion Therapeutics, Inc. - President, CEO & Director

Good afternoon, everybody. Thank you. On behalf of Esperion, the company, all the employees, we're very happy to be here. Thank you to JPMorgan as well for allowing us to be here and share with you what's been really an exciting couple of months and a really exciting couple of days, and we're happy here to share that excitement with you. I have a countdown timer on my phone, although I don't have my phone on me because I can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot